Concepedia

Valentina Rossi

VR

8

Publications

343

Citations

8

H-Index

1999

Active since

Affiliations

University of Naples Federico II(Current)

Università Campus Bio-Medico

Università Cattolica del Sacro Cuore

University of Turin

Sapienza University of Rome

Valentina Rossi is an author at University of Naples Federico II specializing in cell death, medicine, and pharmacology.

ORCID

Top concepts

Publications per year

1999–2019

8

Publications

8

Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2)

Emiliano Cocco, F. Javier Carmona, Pedram Razavi et al. · Science Signaling · 2018 · 72 citations · Full text

Should All Patients With HR-Positive HER2-Negative Metastatic Breast Cancer Receive CDK 4/6 Inhibitor As First-Line Based Therapy? A Network Meta-Analysis of Data from the PALOMA 2, MONALEESA 2, MONALEESA 7, MONARCH 3, FALCON, SWOG and FACT Trials

Valentina Rossi, Paola Berchialla, Diana Giannarelli et al. · Cancers · 2019 · 67 citations · Full text

Effects of somatostatin analog SOM230 on cell proliferation, apoptosis, and catecholamine levels in cultured pheochromocytoma cells

Daniela Pasquali, Valentina Rossi, Giovanni Conzo et al. · Journal of Molecular Endocrinology · 2008 · 62 citations · Full text

, , +18

“Triple positive” early breast cancer: an observational multicenter retrospective analysis of outcome

Patrizia Vici, Laura Pizzuti, Isabella Sperduti et al. · Oncotarget · 2016 · 43 citations · Full text

Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptorα and β

Valentina Rossi, Giuseppe Bellastella, Claudio De Rosa et al. · Journal of Cellular Physiology · 2010 · 41 citations

Rows per page

1–5 of 8